By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Warner-Lambert Company (Merged With Pfizer -- See Pfizer, Inc.) 

201 Tabor Road

Morris Plains  New Jersey  07950-2614  U.S.A.
Phone: 201-540-2000 Fax:



BASF  Research, development and marketing agreement with Warner-Lambert for human therapies based on modulation of Interleukin-1B Converting Enzyme (ICE).


PanVera LLC 

Company News
Former Chief Scientific Officer of Warner-Lambert (PFE) and President of Parke-Davis Pharmaceutical Research Joins Aastrom Biosciences, Inc. (ASTM) Board of Directors 10/26/2010 9:00:35 AM
IVAX Corporation (IVX) Launches Gabapentin Capsules10/19/2005 5:13:06 PM
FDA Grants Alpharma (ALO) Final Approval And First-To-File Status For Gabapentin Tablets10/19/2005 5:11:54 PM
IVAX Corporation (IVX) Provides Gabapentin Update10/19/2005 5:11:47 PM
Johnson & Johnson's (JNJ) Ortho Biotech Products, L.P. Receives Subpoena On PROCRIT(R)10/19/2005 5:11:44 PM
California Verdict Finds Warner-Lambert (PFE) Not Liable In Rezulin Trial10/19/2005 5:11:32 PM
Pfizer Inc. (PFE) Statement On Resolution Of Warner-Lambert (PFE) Neurontin Legal Matters10/19/2005 5:11:17 PM
Pfizer Inc. (PFE) To Pay $430 Million In Marketing Case10/19/2005 5:11:17 PM
IVAX Corporation (IVX) Receives Final Approval On 600 And 800 Mg Gabapentin Tablets10/19/2005 5:10:41 PM
Inverness Medical Innovations, Inc. (IMA) Announces Agreement To Supply Pfizer Inc. (PFE) With A Digital Version Of Its e.p.t(R) Brand Pregnancy Test10/19/2005 5:09:32 PM